Position in SNDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$27,105,393
-$10,314,897 QoQ
Shares Held
1,239,954
-22.6% QoQ
Ownership
1.39%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#26
of 242 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. SNDX ranks #41 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in SNDX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,105,393 | 1,239,954 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $37,420,290 | 1,601,896 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $25,623,984 | 1,219,609 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $16,578,645 | 1,077,585 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $6,036,135 | 644,542 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,675,506 | 787,587 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,434,026 | 184,117 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,782,891 | 352,358 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,010,580 | 146,643 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $202,871 | 8,524 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $906,863 | 41,965 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,157,264 | 148,572 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,621,286 | 173,019 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,937,095 | 139,067 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,083,070 | 160,435 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,076,512 | 128,028 | Shares | Defined | 2022-11-14 | |
| 2021-12-31 | $2,699,102 | 123,303 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,442,860 | 337,146 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,047,717 | 410,467 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $12,833,252 | 573,938 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $14,567,355 | 655,007 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,681,542 | 249,427 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,490,758 | 100,591 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $850,975 | 77,573 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||